The one-year INFUSE study observed patient-reported migraine-related cognitive symptoms at baseline and changes over 6 months in those with at least one prior anti-calcitonin gene-related peptide ...
NEW YORK--(BUSINESS WIRE)--Synchron, a category-defining brain-computer interface (BCI) company, today unveiled the roadmap to Chiralâ„¢, a foundation model of human cognitions, marking the emergence of ...
VYEPTI is indicated for the preventive treatment of migraine in adults. VYEPTI is contraindicated in patients with serious hypersensitivity to eptinezumab-jjmr or to any of its ingredients. Reactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results